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Human liver was homogenised and fractionated by differential centrifugation, and the s&cellular fractions 
were characterised biochemically. Absolute values and distribution patterns of protein and marker enzyme 
activities obtained from human liver have also heen compared with those from rat liver. In addition, acid 
phospholipase activities have been studied in human liver. On the basis of product formation from stereo- 
specifically radiolaheled phosphatidylethanolamine substrates, lysosomal phospholipases A, and A, with 
optimal activities at pH 4.7 have heen identified in human liver. Acid phospholipase C and lysophospholip- 
ase activities, however, were not found in human liver. Cationic amphiphilic drugs inhibited the activities 
of the acid phospholipases A in human and rat liver lysosomes to about the same extent. 
Subcellular fractionation; Marker enzyme; Phospholipase; Chloroquine; Mepacrine; Primaquine; 
(Human liver, Rat liver) 
1. INTRODUCTION 
Human liver bioptic material is an important 
tool for diagnostic purposes. This holds true for 
the absolute amounts and possibly also for the 
subcellular distribution patterns of intracellular 
constituents. The data presented here may serve as 
a basis for clinical studies in the future. In addi- 
tion, our findings provide some new information 
about human liver lysosomal phospholipases and 
their potential inhibition by lipidosis-inducing ca- 
tionic amphiphilic drugs, which have been 
demonstrated in animal tissues to induce in- 
tralysosomal lipid storage by interfering with in- 
tralysosomal lipolytic enzyme activities [l-3]. 
Correspondence address: H. Kunze, Max-Planck- 
Institut fiir Experimentelle Medizin, Hermann-Rein- 
StraBe 3, D-3400 Giittingen, FRG 
2. MATERIALS AND METHODS 
2.1. Substances 
All reagents and solvents used were of analytical 
grade and obtained from Sigma (Miinchen). Triton 
X-100 was from Serva (Heidelberg) and silica gel H 
from E. Merck (Darmstadt). Radioactive fatty 
acids were purchased from Amersham Buchler 
(Braunschweig). The drugs employed here were 
kindly supplied by Bayer (Leverkusen). Synthesis 
of radioactive substrates was performed as de- 
scribed in [4]. 1 -Acyl-2-[ 1-14C]lino1eoyl-sn-glycero- 
3-phosphorylethanolamine had a specific activity 
of 2214 dpm/nmol, 1-[l-‘4C]palmitoyl-2-acyl-sn- 
glycero-3-phosphorylethanolamine of 2617 dpm/ 
nmol, and I-[ 1 -14C]palmitoyl-sn-glycero-3-phos- 
phorylethanolamine of 2055 dpm/nmol. 
2.2. Biological materials 
Human liver from organ donors was supplied by 
the hospital (Universittitsklinikum, Giittingen). 
Subcellular fractions of human liver were isolated 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/87/$3.50 0 1987 Federation of European Biochemical Societies 51 
Volume 216, number 1 FEBS LETTERS May 1987 
Rat Liver 
PERCENTAGE OF TOTAL PROTEIN 
a 22 1 
m3 
E 
2 c 
1 
0 
18 ,- Acid phOSphot0Se 
tS f- P-N-Atrtyi-D-hexos9mlnidDSe 
5 
1 
Cytochrome c ox~dose 
& 
a 3 
u-l 
CL 2 
1 
0 ~ 
N M’P S 
PERCENTAGE OF TOTAL PROTEIN 
Human Liver 
PERCENTAGE OF TOTAL PROTEIN 
6 Actd phosphoiipase A, 
5 
L 
Q 
U-J 3 
u 
2 
1 
0 
9 Acbd phosphotoSP 
5 
L 
;: 3 
cc 
2 
I 
0 i 
6 
5 
a L 
: 3 
2 
1 
0 i 
6 r ()-N-Acetyi-D-herosam,nldose 
5 
4 
a 
v) 
3 
a 
2 
1 
0 ~ 
5 f- Cytochrome c oxldose 
L 
a 3 
UI 
a: 2 
t 
0 j 
N M L P S 
PERCENTAGE OF TOTAL PROTEIN 
Fig.1. Distribution patterns in subcellular fractions of rat and buman liver of severa marker enzymes and of acid 
phospholipases A,. The data derived from 6 (rat liver) and 3 (human liver) fractionations are plotted according to De 
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Duve et al. [5]. RSA, relative specific activity (percentage of total recovered activity divided by percentage of total 
protein in each fraction); N, nuclear fraction; M, heavy mitochondrial fraction; L, light mitochondrial fraction; P, 
microsomal fraction; S, final supernatant. 
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by differential centrifugation [5] from a 20% (w/v) 
homogenate in 0.25 M sucrose. Subcellular frac- 
tions from rat liver were prepared in the same way 
[A. 
2.3. Enzymes 
Several marker enzymes were determined in 
homogenates and in the respective subcellular frac- 
tions. Lactate dehydrogenase (EC 1.1.1.27) was 
measured according to Johnson [6], glucosed- 
phosphatase (EC 3.1.3.9) according to Swanson 
[7], galactosyltransferase (EC 2.4.1.38) according 
to Beaufay et al. [8], monoamine oxidase (EC 
1.4.3.4) according to Wurthman and Axelrod [9], 
cytochrome-c oxidase (EC 1.9.3.1) according to 
Leighton et al. [lo] as modified by Loffler et al. 
[ll], mate oxidase (EC 1.7.3.3) according to 
Hruban and Swift [12] and Beaufay et al. [8], 
catalase (EC 1.11.1.6) according to Baudhuin et al. 
[ 131 and Leighton et al. [lo], acid phosphatase (EC 
3.1.3.2), P-D-glucuronidase (EC 3.2.1.31) and ,& 
N-acetyl-D-hexosaminidase (EC 3.2.1.52) accor- 
ding to Loffler et al. [14], and 5’-adenosine 
monophosphate phosphatase (EC 3.1.3.5) accor- 
ding to Widnell and Unkelen [15] and Glastris and 
Pfeiffer [16] as modified by Loffler et al. [l I]. 
Phospholipase Al (EC 3.1.1.32), A2 (EC 
3.1.1.4) and C (EC 3.1.4.3) activities were 
measured as in [4,11]. The standard incubation 
media contained 25 mM sodium acetate buffer 
(pH 4.7), various amounts of protein (subcellular 
fractions) and 30-55 ,uM sonicated radioactive 
phosphatidylethanolamine substrate in a total 
volume of 250 ~1. They were incubated for 
120 min at 37°C in a shaking water bath, and the 
incubations were terminated by extracting the 
lipids according to Bligh and Dyer [ 171. Blanks 
without enzyme were included in each experiment. 
Determination of hydrolytic activities was per- 
formed after thin-layer chromatography of the 
lipid extracts in order to separate the products (fat- 
ty acids and lysophosphatidylethanolamine) from 
the phosphatidylethanolamine substrate [4,18]. 
For analysis of di- and monoacylglycerols, the 
lipid extract was chromatographed on borate- 
impregnated silica gel H thin-layer plates with 
petroleum ether/diethyl ether/methanol/formic 
acid (60: 40: 1.5 : 1.6, by vol.). Lysophospholipase 
(EC 3.1.1.5) activities were measured as described 
[ 1 I], employing 34-42 ,uM sonicated radioactive 
54 
lysophosphatidylethanolamine substrate in a total 
volume of 250 ~1. Incubations were carried out for 
120 min at 37”C, and the radioactive fatty acids 
released from the substrate were determined as in 
[ll]. All enzyme activities were corrected for 
nonenzymatic hydrolysis of the substrates and ex- 
pressed as initial velocities, in mU/mg, i.e. nmol 
substrate hydrolysed/min per mg protein. 
2.4. Analytical methods 
Protein was determined by the method of Lowry 
et al. [19] using bovine serum albumin as standard. 
3. RESULTS AND DISCUSSION 
Human liver is rich in connective tissue as com- 
pared to rat liver. Hence longer times and higher 
forces were required for homogenisation of the 
human tissue by means of a Potter-Elvehjem 
homogenizer. 
The protein contents and specific activities of 
several marker enzymes in homogenates of human 
and rat liver are presented in table 1. The low pro- 
tein content of human liver may be due not only to 
species differences but also to the excessive perfu- 
Table 1 
Absolute values of various constituents in human and 
rat liver homogenates 
Constituent Rat Human 
Protein 216 f 26 132 f 2 
Acid phosphatase 33.0 I? 3.9 15.5 k 6.6 
P-D-Glucuronidase 3.8 f 2.3 2.8 k 0.1 
,&A’-Acetyl-D-hexos- 
aminidase 37.0 I?Z 10.6 36.9 + 5.4 
Cytochrome-c oxidase 349 f 33 48.7 -t 14.1 
Monoamine oxidase 208 + 5 9.1 f 2.0 
5 ’ -NucleotJdase 62.5 + 2.4 17.2 f 5.5 
Catalase 522 k 97 152 + 36 
Urate oxidase 35.1 f 6.9 ND 
Glucose-6-phosphatase 58.7 f 11.6 7.1 * 2.0 
Lactate dehydrogenase 2574 t- 328 398 Z!Z 18 
Protein values are given in mg protein/g liver wet wt, 
enzyme activities in mU/mg protein (except monoamine 
oxidase in pU/mg protein). ND, not detectable. The 
data represent means + SD of 3-6 experiments 
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sion prior to tissue removal. Also the specific ac- 
tivities of all marker enzymes studied were 
significantly lower in human liver. Only lysosomal 
enzymes exhibited about similar specific activities 
in the livers of both species. The heterogeneous 
ratios of corresponding markers in human and rat 
livers suggest hat, besides the high content of con- 
nective tissue, species differences are the mean 
reasons for the considerably lower specific ac- 
tivities of marker enzymes in the human organ. 
Subcellular fractionations by the differential 
centrifugation technique of De Duve et al. [5] 
when applied to human and rat livers, led to very 
similar distribution patterns of marker enzymes 
(fig. 1). However, there were also some differences. 
In the human as compared to the rat liver, lower 
RSA values of lysosomal and peroxisomal enzymes 
were found in the L- and higher RSA values of 
these markers in the P-fractions. Furthermore, a 
higher RSA value of the endoplasmic reticulum 
marker was calculated in the L-fraction. These 
findings suggest that the buoyant densities of 
the lysosomal, peroxisomal and endoplasmic 
reticulum components of human liver overlap even 
more than the corresponding ones of rat liver. 
The hydrolysis of phosphatidylethanolamine 
was determined under acidic conditions over the 
range pH 3-7. In human liver it was optimal at pH 
4.7 and highest per unit of protein in the L- 
fractions of liver (fig. 1). Hydrolysis proceeded 
linearly with time up to 150 min, employing less 
than 2Opg protein of the lysosomal fraction. 
Under these assay conditions with substrate con- 
centrations of about 50 ,uM sonicated phosphati- 
dylethanolamine, hydrolysis rates of 2.06 f 
0.18 nmol substrate hydrolysed/min per mg pro- 
tein were measured in the L-fraction of human 
liver, and a higher value of 4.17 + 0.52 nmol/min 
per mg protein in the L-fraction of rat liver. The 
products of phosphatidylethanolamine hydrolysis 
by the L-fraction of human liver were free fatty 
acids and l- as well as 2-acyl lysophospholipids, in 
molar ratios of about 2: 1: 1, respectively. No di- 
or monoacylglycerols were formed. These findings 
indicated the presence of phospholipases A1 and 
AZ with about equal hydrolytic potencies and the 
absence of phospholipase C and lysophospholipase 
in lysosomes of human liver. The failure of 
lysosomal acidic lysophospholipase activity was 
also observed with exogenous lysophosphatidyl- 
ethanolamine substrate. Lysophospholipase activi- 
ty in subcellular fractions of human liver was only 
found with a maximum at pH 9.0, and there was 
no activity peak in the range below pH 9.0. The 
distribution pattern of pH 9 lysophospholipase ac- 
tivity in the subcellular fractions of human liver 
(not shown) exactly paralleled that of glucosed- 
phosphatase, and thus indicated that this enzyme is 
linked to the endoplasmic reticulum and not to 
lysosomes. However, acidic lysosomal lysophos- 
pholipase may have been masked by potential en- 
dogenous inhibitors in our assay systems using 
crude subcellular fractions. This is likely since the 
lysophospholipids, which form intralysosomally 
from diacylphospholipids by the action of lyso- 
somal phospholipases Al and AZ, should be 
removed from this intracellular compartment by 
further deacylation or phosphodiester cleavage. 
Otherwise these metabolites accumulate to mem- 
brane-lytic concentrations. 
Acid phospholipase A activities in the L-fraction 
of human liver were inhibited by all cationic am- 
phiphilic drugs used in these studies. Lysosomal 
phospholipase A1 reacted as sensitively as 
phospholipase AZ. Drug concentrations leading to 
50% inhibition amounted to about 1 mM chloro- 
quine, 0.3 mM mepacrine and 0.5 mM prima- 
quine. These drugs possess virtually identical 
inhibitory potencies for acidic phospholipases of 
human and rat liver [ 111. 
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